Cardiovascular risk assessment is mostly science but also an art, in part. Get an at-a-glance review here of the risk factors and algorithms that combine both.
FDA Expands Bempedoic Acid Label to Include Primary, Secondary CV Risk Reduction, With or Without Statins
Bempedoic acid is now the only non-statin therapy indicated for primary CVD prevention, with potential to expand treatment access to millions, said Esperion Therapeutics.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Aspirin Use among Older Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?
Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.
Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose
Aspirin Use among Older Adults Inconsistent with Current Guidelines, According to New Survey
In a survey of adults aged 50-80 years, 57% of those who reported taking aspirin regularly said they do not have a history of CVD.